Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures

Abstract

Considerable interprovincial variation in publicly funded prescription drug plans results in substantial variation in annual expenditures by Canadians with identical prescription burdens. A revised pharmaceutical strategy might reduce these major inequities.